CRP and cancer: RDW was identified as an inflammatory marker in patients with cancer due to its positive association with widely used plasma inflammatory biomarkers such as C-reactive protein (CRP) 43,28,14, erythrocyte sedimentation rate (ESR) 60,47, and interleukin (IL)-6 78 levels.